Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Another Private Placement

<< Previous

Bullboard Posts

Next >>

Comment by riverrrowon Mar 20, 2024 12:46pm

178 Views

Post# 35943108

RE:RE:RE:Another Private Placement

My thought is the share price will need to trade over 50 cents for the tradeable warrants to be exercised. At a share trading price of 40 cents I feel there is too much downside risk of the share price collapsing after exercising the warrants at 35 cents.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023